Ethylene

Ethylene

SCHEMBL973759

C=C.O=C(O)CN(O)c1ccccc1.O=C(O)CN(O)c1ccccc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.43
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
GLA P06280 1/20 0.41
AKR1B1 P15121 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9743711 0.96 NPSR1 (0.46) NPSR1TDP1ALDH1A1KMT2ATSHR
SCHEMBL124582 0.96 NPSR1 (0.46) NPSR1TDP1ALDH1A1KMT2ATSHR
Hydrochloric Acid SCHEMBL9194071 0.93 NPSR1 (0.44) NPSR1TDP1ALDH1A1KMT2ATSHR
Sulfuric Acid SCHEMBL9324944 0.88 HSP90AA1 (0.43) NPSR1TDP1ALDH1A1KMT2ATSHR
Benzene SCHEMBL28328871 0.83 TSHR (0.43) ALDH1A1TSHRGLAL3MBTL1SMN1; SMN2
SCHEMBL28550181 0.83 ALDH1A1 (0.42) NPSR1TDP1ALDH1A1KMT2ATSHR
SCHEMBL9874763 0.81 TSHR (0.55) ALDH1A1KMT2ATSHRPOLBL3MBTL1
SCHEMBL28315420 0.80 NPSR1 (0.44) NPSR1TDP1ALDH1A1KMT2ATSHR
SCHEMBL29602588 0.78 ALDH1A1 (0.45) NPSR1TDP1ALDH1A1KMT2ATSHR
SCHEMBL11144520 0.78 NPSR1 (0.43) NPSR1TDP1ALDH1A1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011131-B1 Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor INFINEON TECHNOLOGIES AG (DE) 2007-07-25 EP claimed
US-6136714-A Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor SIEMENS AKTIENGESELLSCHAFT (DE) 2000-10-24 US claimed
EP-1011131-A1 Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor SIEMENS AKTIENGESELLSCHAFT (DE) 2000-06-21 EP claimed
US-20160028177-A1 ELECTRIC CONNECTION STRUCTURE AND TERMINAL AUTONETWORKS TECHNOLOGIES, LTD. (JP) 2016-01-28 US disclosed
EP-2333135-A1 RUST INHIBITOR AND SURFACE-TREATED METAL MATERIAL AutoNetworks Technologies, Ltd. (JP) 2011-06-15 EP disclosed
US-20110008634-A1 RUST INHIBITOR AND SURFACE TREATMENT METAL MATERIAL AUTONETWORKS TECHNOLOGIES, LTD. (JP) 2011-01-13 US disclosed
EP-1011131-B1 Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor INFINEON TECHNOLOGIES AG (DE) 2007-07-25 EP disclosed
EP-1149052-A1 PROCESS FOR REMOVING ORGANIC AND INORGANIC CONTAMINANTS FROM PHENOLIC STRIPPED SOUR WATER EMPLOYING REVERSE OSMOSIS TEXACO DEVELOPMENT CORPORATION (US) 2001-10-31 EP disclosed
US-6136714-A Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor SIEMENS AKTIENGESELLSCHAFT (DE) 2000-10-24 US disclosed
WO-2000041972-A1 PROCESS FOR REMOVING ORGANIC AND INORGANIC CONTAMINANTS FROM PHENOLIC STRIPPED SOUR WATER EMPLOYING REVERSE OSMOSIS TEXACO DEVELOPMENT CORPORATION (US) 2000-07-20 WO disclosed
EP-1011131-A1 Methods for enhancing the metal removal rate during the chemical-mechanical polishing process of a semiconductor SIEMENS AKTIENGESELLSCHAFT (DE) 2000-06-21 EP disclosed
US-6071413-A INCLUDING SELENIUM AND DIVALENT AND TRIVALENT METAL CATIONS TO REDUCE THE CONCENTRATION OF SELENIUM TEXACO INC. (US) 2000-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110008634-A1 RUST INHIBITOR AND SURFACE TREATMENT METAL MATERIAL CLTC, CLTA, BCAT1 NPSR1 4790/4885TDP1 4720/4885ALDH1A1 1575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.